IBKR vs NBIX · P/E 36, rev $1.46B vs P/E 45, rev $1.77B
Interactive Brokers Group Inc (IBKR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Interactive Brokers Group Inc (IBKR) is a capital markets company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IBKR revenue for 2026-06-30 was $1.46B. Net income was $2.51B. IBKR currently screens at market cap $143.16B and trailing P/E 36.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IBKR currently screens at market cap $143.16B and trailing P/E 36.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IBKR and NBIX stock pages for the full models.
Not investment advice.